BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 23249122)

  • 21. Missing the bull's eye.
    Gilbert ME; Savino PJ
    Surv Ophthalmol; 2007; 52(4):440-2. PubMed ID: 17574068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxychloroquine Screening Alert: Change is in the Wind.
    Marmor MF
    Ophthalmic Surg Lasers Imaging Retina; 2017 Feb; 48(2):96-98. PubMed ID: 28195610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
    Lyons JS; Severns ML
    Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
    Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
    Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal toxicity secondary to Plaquenil therapy.
    Hanna B; Holdeman NR; Tang RA; Schiffman JS
    Optometry; 2008 Feb; 79(2):90-4. PubMed ID: 18215798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
    Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxychloroquine retinopathy: A review of imaging.
    Pandya HK; Robinson M; Mandal N; Shah VA
    Indian J Ophthalmol; 2015 Jul; 63(7):570-4. PubMed ID: 26458473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxychloroquine retinopathy.
    Maturi RK; Folk JC; Nichols B; Oetting TT; Kardon RH
    Arch Ophthalmol; 1999 Sep; 117(9):1262-3. PubMed ID: 10496407
    [No Abstract]   [Full Text] [Related]  

  • 30. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK; Yu M; Weleber RG
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.
    Tzekov R
    Doc Ophthalmol; 2005 Jan; 110(1):111-20. PubMed ID: 16249962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report.
    Hong EH; Ahn SJ; Lim HW; Lee BR
    BMC Ophthalmol; 2017 Jul; 17(1):124. PubMed ID: 28701214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.
    Salu P; Uvijls A; van den Brande P; Leroy BP
    Doc Ophthalmol; 2010 Jun; 120(3):251-64. PubMed ID: 20397038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
    de Sisternes L; Hu J; Rubin DL; Marmor MF
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3415-26. PubMed ID: 26024126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ERG findings in patients using hydroxychloroquine.
    Tzekov RT; Serrato A; Marmor MF
    Doc Ophthalmol; 2004 Jan; 108(1):87-97. PubMed ID: 15104171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinal toxicity found in a patient with systemic lupus erythematosus prior to 5 years of treatment with hydroxychloroquine.
    Chiang E; Jampol LM; Fawzi AA
    Rheumatology (Oxford); 2014 Nov; 53(11):2001. PubMed ID: 25172940
    [No Abstract]   [Full Text] [Related]  

  • 38. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy.
    Lee MG; Kim SJ; Ham DI; Kang SW; Kee C; Lee J; Cha HS; Koh EM
    Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):396-402. PubMed ID: 25425304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of Microperimetry in Detecting Early Retinal Toxicity of Hydroxychloroquine in Children with Juvenile Systemic Lupus Erythematosus.
    Youssef MM; El-Fayoumi D; Sidky MK; Hegazy AI; Marzouk H; Eltanamly RM
    Ophthalmologica; 2017; 237(3):180-184. PubMed ID: 28297699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choroidal Thinning Associated With Hydroxychloroquine Retinopathy.
    Ahn SJ; Ryu SJ; Joung JY; Lee BR
    Am J Ophthalmol; 2017 Nov; 183():56-64. PubMed ID: 28890078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.